Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells

[1]  A. Ohta,et al.  Targeting hypoxia--A(2A) adenosine receptor-mediated mechanisms of tissue protection. , 2004, Drug discovery today.

[2]  D. Grigoryev,et al.  Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. , 2004, American journal of respiratory cell and molecular biology.

[3]  T. Kodama,et al.  The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. , 2002, Journal of atherosclerosis and thrombosis.

[4]  A. Gerbes,et al.  [Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage]. , 2002, Zeitschrift fur Gastroenterologie.

[5]  J. Michel,et al.  Lovastatin Enhances Ecto-5′-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases , 2002, Circulation research.

[6]  A. Ohta,et al.  Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1α in Activated T Lymphocytes* , 2001, The Journal of Biological Chemistry.

[7]  M. Sitkovsky,et al.  Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.

[8]  J. Liao,et al.  Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[9]  D. Altieri,et al.  Statins' benefits begin to sprout. , 2001, The Journal of clinical investigation.

[10]  J. Spychała.  Tumor-promoting functions of adenosine. , 2000, Pharmacology & therapeutics.

[11]  H. Katus,et al.  Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. , 2000, Circulation.

[12]  K. Hirata,et al.  Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC. , 2000, Biochemical and biophysical research communications.

[13]  G. Burnstock,et al.  Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells , 2000, British journal of pharmacology.

[14]  U. Laufs,et al.  3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * , 1999, The Journal of Biological Chemistry.

[15]  H. Zimmermann,et al.  Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. , 1999, Trends in pharmacological sciences.

[16]  J. Egido,et al.  HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. , 1998, Journal of the American College of Cardiology.

[17]  MarieEssig,et al.  3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells , 1998 .

[18]  M. Essig,et al.  3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. , 1998, Circulation research.

[19]  H. Yee,et al.  Atorvastatin in the Treatment of Primary Hypercholesterolemia and Mixed Dyslipidemias , 1998, The Annals of pharmacotherapy.

[20]  A. Ortiz,et al.  3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. , 1998, Circulation research.

[21]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[22]  T. Rea,et al.  HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit. , 1998, Atherosclerosis.

[23]  J. Navarro-Antolín,et al.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. , 1998, The Journal of clinical investigation.

[24]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[25]  L. Thompson,et al.  Ecto‐enzyme and signaling functions of lymphocyte CD 7 3 , 1998, Immunological reviews.

[26]  U. Laufs,et al.  Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase* , 1997, The Journal of Biological Chemistry.

[27]  J. Burnett,et al.  Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[28]  R. V. van Leeuwen,et al.  Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. , 1997, Biochimica et biophysica acta.

[29]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[30]  H. Zimmermann.  BIOCHEMISTRY, LOCALIZATION AND FUNCTIONAL ROLES OF ECTO-NUCLEOTIDASES IN THE NERVOUS SYSTEM , 1996, Progress in Neurobiology.

[31]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[32]  J. Pearson,et al.  Kinetics of extracellular ATP hydrolysis by microvascular endothelial cells from rat heart. , 1995, The Biochemical journal.

[33]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[34]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[35]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[36]  L. Plesner.  Ecto-ATPases: identities and functions. , 1995, International review of cytology.

[37]  B. Howard.  Dyslipidemia in non-insulin-dependent diabetes mellitus [published erratum appears in Endocr Rev 1994 Aug;15(4):438] , 1994 .

[38]  B. Howard,et al.  Dyslipidemia in non-insulin-dependent diabetes mellitus. , 1994, Endocrine reviews.

[39]  B. Cronstein.  Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[40]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[41]  R. Berne,et al.  Protective Effects of Adenosine In Myocardial Ischemia , 1992, Circulation.

[42]  R. Smolenski,et al.  Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. , 1990, Journal of chromatography.

[43]  E. Dickinson,et al.  The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. , 1989, The Journal of biological chemistry.

[44]  A. Endo.  3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors. , 1981, Methods in enzymology.

[45]  J. Pearson,et al.  Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. , 1980, The Biochemical journal.

[46]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[47]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[48]  N. Kaplan,et al.  Functions of the Two Forms of Lactic Dehydrogenase in the Breast Muscle of Birds , 1963, Nature.